Upgrade to SI Premium - Free Trial

RBC Capital Reiterates Sector Perform Rating on Gilead Sciences (GILD)

June 1, 2026 7:47 AM
RBC Capital analyst Brian Abrahams reiterated a Sector Perform rating and $122.00 price target on Gilead Sciences (NASDAQ: GILD).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments